A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
PubMed Ng, F.M., Sun, J., Sharma, L., Libinaki, R., Jiang, W.J., & Gianello, R
They are not : A guaranteed fat-loss shortcut The same thing as aesthetic fat-dissolving injections A replacement for nutrition, activity, sleep, or medical care Think of lipotropic injections as a support tool
Orders placed in Bangkok may qualify for same-day or next-day dispatch, with tracked shipping available nationwide